As the Senior Vice President, Regulatory Affairs/Quality Assurance, Mr. Timothy Urschel brings more than 30 years of regulatory affairs and quality assurance experience to DP Clinical. He has worked in small biotechs, large international pharmaceutical companies, and CROs. He has experience interacting with numerous health authorities and understands the nuances of global regulatory activities. He has a proven track record of filing numerous successful INDs and NDAs.
Prior to joining DP Clinical, Mr. Urschel held Quality Assurance and Regulatory positions at Onoconova Therapeutics, Daiichi Sankyo Pharmaceuticals, Asubio Pharmaceuticals, Transave, Inc. (now Insmed, Inc.), and Celgene Corporation.
Mr. Urschel holds an MBA in Pharmaceutical Studies from Farliegh-Dickinson University in Rutherford, New Jersey and a BS in Medicinal Chemistry from State University of New York at Buffalo in Buffalo, New York. He also holds a current certification from the Society of Quality Assurance as a Registered Quality Assurance Professional in GCPs, and Pharmaceutical Quality Assurance Certification in GMPs from the New Jersey Pharmaceutical Quality Control Association.
